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Abstract
Introduction: Left atrial appendage occlusion procedure 
(LAAO) became an alternative method for stroke prevention in 
atrial fibrillation (AF) patients with contraindication or intoler-
ance for oral anticoagulation therapy. However, LAA anatomy 
is complex with several different types of LAA morphology. 
Therefore matching the correct size of a delivery device to LAA 
morphology is difficult. In such circumstances, the 3D-printed 
model of LAA closure may be useful for preoperative planning 
which increases the efficacy of LAAO procedure. 
Material and methods: We report as a first 2 cases of LAA 
occlusion procedure using 2 different systems: thoracoscopic 
AtriClip and the LARIAT device in which a 3D printed LAA mod-
el was used in preoperative planning. 
Results: In the first patient, preoperative measurements of 3D 
LAA model were performed using a dedicated selection guide 
for AtriClip device were comparable with the intraoperative 
examination. Left atrial appendage was closed epicardial us-
ing 40 mm size AtriClip. In second patients, LAA closure was 
performed completely percutaneously using LARIAT device. For 
better visualization of LAA shape on fluoroscopy and TEE ex-
amination, intraoperatively sterilized 3D LAA model was used 
during the procedure. In both cases, intraoperative TEE exami-
nation confirmed complete LAA closure with no leak.
Conclusions: Left atrial appendage 3D model is a useful tool in 
preoperative planning of a left atrial appendage occlusion us-
ing epicardial approaches with thoracoscopic or percutaneous 
access using LARIAT device. The quality of low-cost 3D printed 
LAA model is sufficient in planning minimally invasive proce-
dure.
Key words: 3D printing, left atrial appendage, stroke, left atrial 
appendage occlusion, LARIAT, AtriClip.
Streszczenie
Wstęp: Zabiegi zamykające uszko lewego przedsionka (LAAO) są 
alternatywną metodą profilaktyki udarów u pacjentów z migota-
niem przedsionków z przeciwwskazaniami do doustnej antykoagu-
lacji. Ze względu na różnorodną budowę uszka lewego przedsionka 
(LAA) wyróżnia się kilkanaście różnych typów morfologicznych. 
Z tego powodu dopasowanie implantowanego urządzenia do mor-
fologii LAA bywa czasami problematyczne. Wydruk 3D modelu LAA 
może okazać się skutecznym narzędziem w przedoperacyjnym pla-
nowaniu zabiegów, zwiększającym ich skuteczność. 
Materiał i metody: Przedstawiamy jako pierwsi na świecie wyniki 
dwóch zabiegów, w których wykorzystano druk 3D podczas wy-
konywania LAAO z dwóch różnych dostępów: torakoskopowego 
z zastosowaniem AtriClip oraz przezskórnego z zastosowaniem 
epikardialnego urządzenia LARIAT.
Wyniki: U pierwszego pacjenta przedopercyjny pomiar modelu 3D 
z wykorzystaniem urządzenia pomiarowego AtriClip był zgodny 
z śródoperacyjnym pomiarem wielkości LAA. Uszko lewego przed-
sionka zostało zamknięte za pomocą urządzenia AtriClip 40 mm. 
W drugim przypadku zabieg zamknięcia LAA wykonano całkowicie 
przezskórnie z zastosowaniem urządzenia LARIAT. W celu uzyska-
nia lepszej wizualizacji LAA podczas zabiegu, w trakcie fluoroskopii 
oraz TEE stosowano wysterylizowany model 3D, który był dostępny 
dla operatora podczas procedury. W obu przypadkach kontrolne 
badania TEE wykazały całkowite zamknięcia LAA bez obecności 
przecieków.
Wnioski: Model 3D LAA jest skutecznym narzędziem ułatwiającym 
zaplanowanie oraz przeprowadzenie LAAO z dostępu torakoskopo-
wego oraz zabiegów przezskórnych z zastosowaniem urządzenia 
LARIAT. Jakość wydruku niskobudżetowego modelu 3D jest wystar-
czająca do planowania zabiegów małoinwazyjnych. 
Słowa kluczowe: druk 3D, uszko lewego przedsionka, udar, 
zamknięcie uszka lewego przedsionka, LARIAT, AtriClip.
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Introduction
Atrial fibrillation (AF), the most common arrhythmia, in-
creases the risk of stroke 5-fold. More than 90% of strokes 
begin with thrombus formation in the left atrial append-
age (LAA) [1]. Oral anticoagulation (OAC) therapy is the gold 
standard in reducing thromboembolic risk in patients with 
AF and it is recommended for patients with a CHA2DS2-VAS 
score ≤ 2 [2, 3].
However, for many patients oral anticoagulation ther-
apy is ineffective, contraindicated or refused for various 
reasons [4, 5]. For those patients, current guidelines of the 
European Society of Cardiology recommend LAA closure as 
an alternative option for ischemic stroke prevention (class 
IIb, level B) [2].
Left atrial appendage occlusion (LAAO) may be per-
formed using different systems and techniques [6]. Surgical 
closure of the LAA may be carried out as part of a cardiac 
procedure [7] or as totally minimal thoracoscopic occlusion 
using AtriClip [8]. Percutaneous LAAO may be performed 
using endocardial approaches [9] or an epicardial approach 
using the LARIAT device [10, 11]. However, because of vari-
ous differences in LAA morphology and anatomy, there are 
no ideal minimally invasive systems to occlude all types of 
LAA [12]. Therefore, the minimally invasive LAAO is followed 
by procedural imaging: transesophageal echocardiography 
(TEE), fluoroscopy, computed tomography (CT) scan or endo-
scopic camera [8–10]. Despite that, matching the correct size 
of a delivery device to LAA morphology in some cases may 
be difficult. In such circumstances a 3D-printed (3DP) model 
of LAA closure may be useful for preoperative planning and 
increases the efficacy of the LAAO procedure.
Aim
Herein we describe the first 2 cases of LAA occlusion 
using 2 different systems: thoracoscopic AtriClip and the 
LARIAT device using 3DP. 
Material and methods
Computed tomography scans were acquired and im-
ported as DICOM files into 3D Slicer software [13] for analy-
sis and further processing. Semi-automated segmentation 
was performed using thresholding and region-growing 
tools. We decided to use a hollow shell approach, as de-
scribed by Muñiz [14]: segmentation was executed on 
blood poll, arbitrary thickness was added and inside sub-
tracted from the structure. Results of segmentation – vir-
tual models – were exported as STL (stereolithography) files 
and subsequently edited in Blender (Blender Foundation, 
Amsterdam, Netherlands; open-source software) to ensure 
models were manifold and to decide whether and how they 
should be divided for 3D printing. For division, we used the 
plane cut technique with Boolean operations. Final models 
were imported into the open source slicing software Cura 
(Version 2.4; Ultimaker, Geldermalsen, Netherlands), which 
automatically prepares STL files to be ready for 3D printing.
An Ultimaker 2+ 3D printer was used for printing mod-
els with polylactic acid (PLA) as a material. Printing time 
was approximately 5 h and 50 g of PLA were used. Assum-
ing the median price of PLA filament as $35 per kilogram, 
the cost of materials used to print one LAA model can be 
estimated at less than $2.
All procedures performed in studies involving human 
participants were in accordance with the ethical standards 
of the institutional and/or national research committee 
and with the 1964 Declaration of Helsinki and its later 
amendments or comparable ethical standards.
Informed consent was obtained from all individual par-
ticipants included in the study.
Case 1
A 66-year-old man with persistent AF treated with ri-
varoxaban (1 × 20 mg/day, last dose intake on the day of 
stroke) was admitted to our hospital because of ischemic 
stroke. The CHA2DS2-VASc score was 6 for hypertension, 
stroke, age, diabetes mellitus and vascular disease. The 
HAS-BLED score was 5 for hypertension, stroke, age, drug 
and alcohol. Because of high risk of stroke and bleeding, 
the patient was qualified for elective epicardial percuta-
neous LAA ligation using the LARIAT device. Two months 
after the initial stroke, the patient was readmitted to our 
hospital as a result of new episodes of transient ischemic 
attack (TIA). Performed cardiac CT angiography identified 
a thrombus in the LAA, despite approximately 2 years of 
therapeutic anticoagulation therapy with rivaroxaban. 
Transesophageal echocardiography was performed for con-
firmation. Therefore, rivaroxaban was switched to warfa-
rin, with target international normalized ratio (INR) 3. Six 
weeks later, control TEE showed no evidence of a mobile 
clot in LAA. However, in the distal part of the LAA there was 
a suspected thrombus. Therefore, the patient was requali-
fied for thoracoscopic LAA closure with AtriClip.
Prior to the procedure, based on the patient’s angio-CT, 
a model of the LAA was 3D-printed. Preoperative measure-
ments of the 3D LAA model were performed using a dedi-
cated selection guide for the AtriClip device (Fig. 1), which 
estimated the LAA length at approximately 40 mm.
The procedure was performed under general anesthe-
sia with intraoperative TEE examination. A double lumen 
intratracheal tube was used to perform single right lung 
ventilation. Thoracoscopic access was performed using 
one port for the endoscopic camera (the fourth intercostal 
space in the anterior axillary line) and two working ports 
(the third and sixth intercostal spaces at the midaxillary 
line into the left pleura) with CO2 insufflation. For visualiza-
tion of the LAA, left pericardiectomy was performed. Intra-
operative measurements of the LAA, using the same dedi-
cated selection guide, showed 40 mm length of the LAA 
base (Fig. 2). The preoperative 3D LAA model and intraop-
erative measurements of LAA were comparable. After mea-
surement, a 40 mm size AtriClip was introduced through 
the sixth intercostal port. Intraoperative TEE examination 
confirmed complete LAA closure with no leak. There were 
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no intraoperative or postoperative complications. The pa-
tient was discharged 5 days after the procedure.
Case 2
A 60-year-old man with persistent AF treated with dabi-
gatran (2 × 150 mg/day, last dose was taken on the day of 
stroke), was admitted to our hospital because of an isch-
emic stroke. The CHA2DS2-VASc score was 4 for congestive 
heart failure, hypertension and stroke. The HAS-BLED score 
was 3 because of hypertension, stroke and drug intake. 
Due to the high risk of stroke and bleeding the patient was 
qualified for elective epicardial percutaneous LAA ligation 
with the LARIAT device. One month after stroke pre-proce-
dure cardiac CT showed a thrombus mass in the LAA de-
spite one year of anticoagulation therapy with dabigatran. 
Dabigatran therapy was switched to warfarin therapy, with 
target INR 3 for 2 months. After this time, TEE examination 
showed a persistent picture of LAA thrombus. Anticoagula-
tion therapy was again switched from warfarin therapy to 
low molecular weight heparin therapy (LMWH) (2 × 60 mg 
enoxaparin/day) and aspirin (1 × 150 mg/day) for the next 
2 months. Afterwards, control TEE again showed a persis-
tent picture of thrombus in the LAA. Previous anticoagula-
tion therapy was maintained. After 2 months another TEE 
examination was performed and no clot or thrombus in 
LAA was observed. 
Prior to the procedure, based on the patient’s angio-CT, 
an LAA 3D model was printed (Fig. 3) and sterilized (Fig. 4).
Epicardial LAA closure using the LARIAT device has been 
previously described in our study [6, 10]. The procedure 
was performed completely percutaneously. All procedural 
steps were performed using fluoroscopy and TEE naviga-
tion. For better visualization of LAA shape on fluoroscopy 
and TEE examination, an intraoperatively sterilized 3D LAA 
model was used. Access to the LAA was obtained by punc-
ture of the pericardium and standard transseptal access. 
After that, the endocardial magnet-tipped guide-wire with 
a balloon for LAA identification was placed in the LAA apex. 
To stabilize the connection, epicardial and endocardial 
magnet-tipped guide-wires were used. Through epicardial 
access, the LARIAT snare was placed on the proximal end 
of the LAA. The loop stitch was tightened and after confir-
mation of complete closure of the LAA with Doppler TEE, 
the suture was released. All steps were performed using 
fluoroscopy and TEE navigation. 
There were no intraoperative or postoperative compli-
cations. The patient was discharged 5 days after the pro-
cedure.
Discussion
We have presented 2 cases of LAA occlusion using 2 dif- 
ferent systems with 2 different approaches. The thoraco-
scopic approach with the AtriClip was guided by an endo-
scopic camera and TEE. Percutaneous epicardial closure 
with the LARIAT device was guided by fluoroscopy and TEE. 
In both cases, a 3D printed, patient-specific LAA model, 
based on a CT scan, was a useful tool in planning the pro-
cedure and selecting the right size of delivery device. To the 
best of our knowledge this is the first study that describes 
the use of a 3D printed model for LAAO closure with the 
LARIAT device. 
Atrial fibrillation increases the risk of stroke 5–6-fold, 
and one in five of all brain strokes are due to this arrhyth-
mia. Over 90% of all thrombi in patients with AF are formed 
in the LAA [1]. Compared to the rest of the heart chambers, 
the LAA is anatomically prone to stasis by virtue of hav-
ing a long, tubular structure as well as a narrow junction 
with the atrium. Both LAA anatomy as well as turbulent 
and low velocity of blood flow in the LAA have a significant 
influence on thrombus formation [12]. Therefore the LAAO 
procedure has become an alternative method for thrombo-
embolism prevention in patients with AF [2].
A published study showed that LAA anatomy is com-
plex. There may be more than 7 different types of LAA 
shape, and LAA morphology, size, volume, orifice axis, 
cross-sectional area and number of lobes vary in the gen-
eral population [15]. It is said that the shape of the LAA is 
individual for each patient, like a fingerprint. 
To avoid an undersized or oversized LAA delivery de-
vice in the LAAO procedure, knowledge of LAA anatomy is 
Fig. 1. Preoperative measurement of 3D LAA model Fig. 2. Intraoperative thoracoscopic measurement of LAA
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a key to perform a successful procedure. A previous study 
of the LAAO procedure showed that the actual size of the 
selected occluding devices was frequently 20–40% larger in 
diameter than predicted by transesophageal echocardiog-
raphy [15, 16]. To avoid mismatching of delivery device size 
and LAA anatomy, in some cases it is necessary to perform 
up to 4 attempts, which increases the risk of procedural 
complications [17]. The use of a correct imaging technique 
is also an important factor for proper LAA measurement. 
Results of LAA measurements performed by TEE are un-
derestimated in comparison to cardiac CTA [18], but on the 
other hand, cardiac CTA overestimates measurements of 
LAA angiography [19]. 
3DP is a new technology that has been used with suc-
cess as a preoperative planning tool in creating patient-
specific models for many fields of surgery [20, 21], including 
cardiac procedures [22–25]. Cardiac 3D models are created 
from DICOM files from CTA with customized software. In 
the LAAO procedure, the use of 3D printed models allows 
one to specify each patient’s unique anatomy of the LAA 
and spatial anatomical relationship. This additional tool is 
very useful in preoperative preparation before the LAAO 
procedure and proper selection of the delivery device. 
We found that, in thoracoscopic cases, results of pre-
operative LAA 3D model measurements by the Gillinov-
Cosgrove Selection Guide for AtriClip were identical to the 
LAA dimension measured intraoperatively (Figs. 1, 2). In the 
second case, when we used a percutaneous approach with 
the LARIAT device followed only by TEE and fluoroscopy im-
ages, the LAA 3D model allowed the LAA structure to be vi-
sualized as a spatial model. This, in our opinion, facilitated 
the procedure, which is technically demanding. Moreover, 
in all cases, we made only 1 attempt to occlude the LAAO. 
What is important, the LAA 3D model which was printed 
from a commercial 3D printer was successfully sterilized 
and used directly on the operative field (Fig. 3).
In the literature there are only a few reports describing 
application of a 3D model in the LAAO procedure. However, 
this study analyzes only application of 3D in a percutaneous 
endocardial approach [23, 24, 26]. Herein we present, for 
the first time, application of a 3D model in LAAO closure us-
ing both epicardial approaches: surgical and percutaneous. 
There are several challenges in applying 3D-printed 
models to routine practice. Each model is patient-specific. 
Until now on the market there is no software that auto-
matically converts the DICOM format obtained from a CT 
scan to the STL format required for a 3D printer. Therefore 
this required a skilled physician or trained technicians with 
good knowledge of radiological as well as clinical anatomy 
to provide a realistic 3D model. Another limitation is the 
high costs. Many papers have estimated costs associated 
with 3D printing of an LAA model at $300 [24], which is 
significantly more expensive when compared with the ap-
proach described above. It is because of different fabrica-
tion methods: in our case it was fused deposition modeling 
(FDM), the most affordable one. Some authors use tech-
niques that require high-priced hardware and materials, 
such as PolyJet [26–28], stereolithography (SLA) or selective 
Fig. 4. 3D LAA model sterilizedFig. 3. 3D LAA model printed for LARIAT procedure
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laser sintering (SLS). It is also important that most papers 
on 3D printing LAA models do not discuss the costs related 
to the process at all [26–29]. Another fact worth mention-
ing is that it is very difficult to estimate costs associated 
with manual work required to handle the 3D printing pro-
cess, as most of the models are prepared by pioneers and 
not hired specialists.
Another limitation of clinical 3D printing is the time 
frame required to develop a single model. On the one 
hand, it is possible to create a fully personalized physical 
3D model of a patient’s anatomy in less than a day. On 
the other hand, it still takes several hours to process, print 
and assemble the model, which makes 3D printing not 
possible to help in urgent cases. Having said that, there is 
a field for other visualization techniques including virtual 
or augmented/mixed reality that reduce the time needed 
to perform segmentation. However, for many surgeons it 
is important to have a physical 3D model, and they favor 
this approach over virtual reality visualization. Also, physi-
cal models allow one to perform simulations, mock proce-
dures and selection of proper device size. These tasks are 
not fully possible using currently available software and 
other techniques. 
Conclusions
The LAA 3D model is a useful tool in preoperative plan-
ning of a left atrial appendage occlusion with thoracoscopic 
or percutaneous access using the LARIAT device. The qual-
ity of low-cost 3D printed LAA model is sufficient in plan-
ning a minimally invasive procedure.
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